IL15 and cranioectodermal dysplasia: Therefore, it has been proposed that IL-15 plays a key role in immune-mediated tissue destruction [9], and treatments aimed at neutralizing its effects could be considered strategic in normalizing intestinal immune homeostasis in CeD patients.